ArticleHead and neck pathology2025
Recurrent Diffuse Tenosynovial Giant Cell Tumor of the Temporomandibular Joint.
Article in Head and neck pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeRecurrent diffuse-type tenosynovial giant cell tumor: Clinical presentation, Diagnosis, and Management.
backgroundTenosynovial giant cell tumor (TGCT), is a neoplasm arising from synovial joints, bursae, or tendon sheaths. The initial clinical symptoms are vague and non-diagnostic. Patients may present with non-specific complaints such as subtle joint discomfort or pain. As the lesion progresses, the joint range of motion will become limited resulting in swelling, effusion, stiffness, and hemarthrosis. According to the World Health Organization (WHO) classification, TGCTs are divided into two main subtypes based on their growth pattern: localized or diffuse. Diffuse-type TGCTs tend to be more aggressive. CASE PRESENTATION: An 82-year-old female presented with right facial swelling and discomfort. MRI showed a large mass centered in the right temporomandibular joint (TMJ) with erosive osseous changes at the skull base. Past medical history was significant for surgical resection of TGCT of the TMJ, 5 years earlier. The patient was subsequently seen by oral and maxillofacial surgery and neurosurgery and underwent a surgical resection. Histologic examination was consistent with a recurrent diffuse-type TGCT with chondroid metaplasia. DISCUSSION: The role of CSF1 protein over-expression in various synovial pathologies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.